Uncategorized


June 25, 2026

[CVS, Walgreens, Muni Hospitals]: Cassidy 340B Draft Capping Contract Pharmacies and Overseeing 340B Face Long Odds; Other Regulatory Actions Likely in Motion

By Beth Steindecker

Senate HELP Chairman Bill Cassidy’s (R-LA) recently introduced 340B Drug Pricing Integrity and Affordability for Patients Act raises threats to 340B contract pharmacies (both brick-and-mortar and mail-order) [CVS and private Walgreens, and to a much…

Read More >>

June 25, 2026

[DVA, FRE.DE, Innovative Renal] Medicare Proposal: Large Dialysis Chains Do Relatively Better but Phosphate Binder Policy Falls Short

By Beth Steindecker

CMS’s CY27 proposed Medicare end-stage renal disease (ESRD) payment rule is likely to leave dialysis providers [DVA, FRE.DE, private Innovative Renal] somewhat disappointed. The agency declined to extend the transitional drug add-on payment adjustment (TDAPA)…

Read More >>

June 23, 2026

(NXST, SBGI, GTN, SSP, DIS, CMCSA, PSKY, FOXA) FCC 39% TV Ownership Cap: Deregulation Is Near-Term; Litigation Risk Is Medium-Term

By Joe Lieber

We believe the FCC is very near to formally eliminating the 39% national television ownership cap, with the final rule now at the Office of Information and Regulatory Affairs (OIRA) within the OMB. The agency…

Read More >>

June 23, 2026

Healthcare REITs, Hospitals, Nursing Homes: Status of State Legislative Efforts to Intensify Oversight of Healthcare Transactions

By Beth Steindecker

With only a handful of state legislatures still in session and most adjourned for the year, our review of state efforts to expand oversight of or impose restrictions on material changes in hospitals and healthcare…

Read More >>

June 22, 2026

Capitol Policy Weekly: CLARITY Clock, Iran Talks, Housing Overread, and Reconciliation Update

By Joe Lieber

The House and Senate are both in session this week, as the pre-August calendar is becoming the biggest obstacle for several Republican priorities that need to be worked out. We continue to believe the Digital…

Read More >>

June 18, 2026

[HUM, UNH, CVS, ELV, CNC, ALHC, MOH, CLOV, CI]: CMS Recalculates 2026 Star Ratings in Light of CLOV Ruling, But Financial and Legal Questions Remain

By Beth Steindecker

CMS informed Medicare Advantage (MA) insurers [HUM, UNH, CVS, ELV, CNC, ALHC, MOH, CLOV] that it is voluntarily recalculating their CY26 Star Ratings, which determine CY27 Quality Bonus Payments (QBP). Under the agency’s approach, released…

Read More >>

June 17, 2026

(NVDA, AMD, GOOGL, META, CRWV, Anthropic, OpenAI) AI Regulation: State Patchwork, Federal Export Controls, and NDAA Chip Watch

By Joe Lieber

We remain skeptical that Congress will pass comprehensive federal AI legislation this year or likely next year, leaving companies to navigate a state-by-state regulatory patchwork since no current federal law exists that broadly preempts state…

Read More >>

June 17, 2026

Rx MFN: Sector Risk Inbound?

By John Leppard

Yesterday’s disclosure by the Office of Management & Budget (OMB) that it is reviewing a finalized Medicare Part D Most Favored Nation (MFN) policy suggests the administration likely intends to move forward with its late…

Read More >>

June 16, 2026

EW: TAVR Draft Coverage Puts & Takes

By John Leppard

CMS’s draft coverage policy for transcatheter aortic valve replacement (TAVR) appears largely consistent with our initial expectations, likely bringing some incremental upside as well. If finalized largely as proposed in Sept., as seems probable, we…

Read More >>

June 15, 2026

[OSCR, CNC, ELV, HCA, THC, CYH, UHS]: ACA Court Win Offers Limited Relief as Obamacare Enrollment Headwinds Remain

By Beth Steindecker

Last week’s ACA-related court ruling permanently, which enjoined key portions of the CY25 Obamacare regulation, may initially reassure insurers [OSCR, CNC, ELV] and hospitals [HCA, THC, CYH, UHS, ARDT] about certain enrollment-related program integrity headwinds….

Read More >>